Literature DB >> 12728122

Medication use in the treatment of pediatric insomnia: results of a survey of community-based pediatricians.

Judith A Owens1, Carol L Rosen, Jodi A Mindell.   

Abstract

OBJECTIVES: To examine clinical practice patterns, beliefs, and attitudes regarding the use of both nonprescription and prescription medications by community-based pediatricians for children with significant difficulties in initiating and/or maintaining sleep.
METHODS: A survey was mailed to 3424 American Academy of Pediatrics members in 6 US cities.
RESULTS: The final sample (n = 671) consisted of practitioners who identified themselves as primary care pediatricians. Three percent +/- 7% of visits in the respondents' practices were for pediatric insomnia, although there was a wide range in the numbers of children identified during a typical 6-month practice period. More than 75% of practitioners had recommended nonprescription medications, and >50% had prescribed a sleep medication. Specific clinical circumstances in which medications were most commonly used were acute pain and travel, followed by children with special needs (mental retardation, autism, and attention-deficit/hyperactivity disorder). Antihistamines were the most commonly reported nonprescription medications for sleep. Melatonin or herbal remedies had been recommended by approximately 15% of the respondents. alpha-agonists were the most frequently prescribed sleep medications (31%). The likelihood of prescribing medication for sleep was 2- to 4-fold greater in respondents who treated children with attention-deficit/hyperactivity disorder for daytime behavioral problems or nocturnal sleep problems, respectively. Practitioners expressed a range of concerns about sleep medication appropriateness, safety, tolerance, and side effects in children.
CONCLUSIONS: The practice of prescribing or recommending sedatives and hypnotics for pediatric insomnia is common among community-based pediatricians, especially among special needs patients. An empirically based approach to the use of these medications is needed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12728122     DOI: 10.1542/peds.111.5.e628

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  34 in total

1.  Prevalence of diagnosed sleep disorders in pediatric primary care practices.

Authors:  Lisa J Meltzer; Courtney Johnson; Jonathan Crosette; Mark Ramos; Jodi A Mindell
Journal:  Pediatrics       Date:  2010-05-10       Impact factor: 7.124

2.  Behavioral parent training to address sleep disturbances in young children with autism spectrum disorder: a pilot trial.

Authors:  Cynthia R Johnson; Kylan S Turner; Emily Foldes; Maria M Brooks; Rebecca Kronk; Luci Wiggs
Journal:  Sleep Med       Date:  2013-08-27       Impact factor: 3.492

3.  Association between short sleeping hours and overweight in adolescents: results from a US Suburban High School survey.

Authors:  Andreea Seicean; Susan Redline; Sinziana Seicean; H Lester Kirchner; Yuan Gao; Michikazu Sekine; Xiaobei Zhu; Amy Storfer-Isser
Journal:  Sleep Breath       Date:  2007-12       Impact factor: 2.816

4.  What is the role of melatonin in the management of sleep disorders in children?

Authors:  Nina Buscemi; Manisha Witmans
Journal:  Paediatr Child Health       Date:  2006-10       Impact factor: 2.253

Review 5.  Sleep disorders and attention-deficit/hyperactivity disorder.

Authors:  Judith A Owens
Journal:  Curr Psychiatry Rep       Date:  2008-10       Impact factor: 5.285

6.  Ramelteon for Insomnia Related to Attention-Deficit/Hyperactivity Disorder (ADHD).

Authors:  Rachel E Fargason; Karen Gamble; Kristin T Avis; Rachel C Besing; Cherry W Jackson; Marshall E Cates; Roberta May
Journal:  Psychopharmacol Bull       Date:  2011-05-15

Review 7.  Sleep Disruption in Pediatric Cancer Survivors: Conceptual Framework and Opportunities for Clinical Assessment and Behavioral Treatment.

Authors:  Erin L Merz; Lianne Tomfohr-Madsen
Journal:  Am J Lifestyle Med       Date:  2016-12-08

8.  The non-benzodiazepine hypnotic zolpidem impairs sleep-dependent cortical plasticity.

Authors:  Julie Seibt; Sara J Aton; Sushil K Jha; Tammi Coleman; Michelle C Dumoulin; Marcos G Frank
Journal:  Sleep       Date:  2008-10       Impact factor: 5.849

9.  The sedating antidepressant trazodone impairs sleep-dependent cortical plasticity.

Authors:  Sara J Aton; Julie Seibt; Michelle C Dumoulin; Tammi Coleman; Mia Shiraishi; Marcos G Frank
Journal:  PLoS One       Date:  2009-07-01       Impact factor: 3.240

10.  A clinical overview of sleep and attention-deficit/hyperactivity disorder in children and adolescents.

Authors:  Judith A Owens
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2009-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.